Skip to main content

Table 3 Studies comparing integrated to non-integrated treatment

From: Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis

Study

n

Groups

Design

Measure

d (SE)

p

Study Quality

Barkauskas and Low46

Treatment: 52

Control: 73

Residential program for pregnant, incarcerated women vs standard prison care for women

Quasi- Experimental

% positive toxicology screens

-0.29† (0.69)

0.669

5/9

Carroll and Chang 40

Treatment: 7

Control: 7

Enhanced methadone treatment for women vs standard methadone treatment for women

Randomized Trial

% positive toxicology screens

-0.14† (0.67)

0.83

1/5

Chang and Carroll 47

Treatment: 6

Control: 6

Enhanced methadone treatment for women vs standard methadone treatment for women

Quasi- experimental

% positive toxicology screens

0.43† (0.70)

0.54

3/9

Gwadz and Leonard39

Treatment: 51

Control: 58

Integrated outpatient treatment for women vs standard outpatient treatment for women

Randomized Trial

National Alcohol Survey - Frequency of Alcohol Use

-0.12 (0.19)

0.545

1/5

    

Drug Use Screen Inventory - Alcohol/Dru g Problems

0.077 (0.19)

0.69

 
    

Risk Behaviour Assessment - Frequency of Drug Use

-0.26 (0.19)

0.183

 

Harshman66

Treatment: 25 Control: 27

Residential Integrated treatment for women vs Co-ed Residential Standard treatment

Quasi- experimental

# months since last used substances

-0.15 (0.28)

0.593

2/9

    

SASSI-2 * Alcohol use

0.61 (0.28)

.033

 
    

SASSI-2 drug use

0.06 (0.28)

0.83

 

Luthar et al. 41

Treatment: 60 Control: 67

Maternal psychotherapy plus standard methadone treatment vs. Recovery training plus standard methadone treatment

Randomized Trial

Positive toxicology screens - opiate use (follow up phase - up to one year follow up)

-0.08† (0.18)

0.647

3/9

    

Positive toxicology screens - cocaine use (treatment phase)

0.25 (0.18)

0.170

 
    

Positive toxicology screens - cocaine use (follow up phase - up to one year follow up)

-0.14 † (0.18)

0.428

 

Sacks and Sacks 67

Treatment: 49

Control: 49

Residential integrated treatment for women vs co-ed standard residential treatment

Quasi- experimental

Substance Use Composite (incl. Drug use, frequency of use, # days of use)

0.12â—Š

NS

3/9

Sowers and Ellis48

Treatment: 26

Control: 15

Residential integrated treatment for women vs standard day treatment (not specified if women only)

Quasi- experimental

% not using any substances

0.33 (0.36)

0.36

4/9

Suchman and Mayes 49

treatment: 25

control: 23

Women only outpatient treatment with parenting intervention vs standard women only outpatient treatment

Quasi- Experimental

% not using any substances

0.15 (0.30)

0.628

3/9

Touissaint and VanDeMar k68

Treatment: 64

Control: 106

Residential Integrated Treatment for women vs Co-ed Residential Standard Treatment

Quasi- experimental

Addiction Severity Index Drug Composite

0.30 (0.16)

.059

6/9

    

Addiction Severity Index Alcohol Composite

0.28 (0.16)

0.078

6/9

  1. † Included in overall effect size for toxicology screens
  2. * Substance Abuse Subtle Screening Inventory-2
  3. â—Š effect size reported, data on SE and p not available
  4. Significance of d based on test of null (z-test)